Work

811MO Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1

Year: 2020
Type: article
Study design: Clinical Trial
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3088796366
FWCI: 5.7
Cites:
Cited by: 74
Related to: 10